MoneyWorks4Me

The Total revenue for the quarter ended March 2023 of  Rs. 5872.10 millions remain, more or less, the same.The company almost doubled its revenue to Rs. 652.70 millions  from Rs. 277.50 millions in the quarter ended March 2023.Operating profit for the quarter ended March 2023 rose to 1045.10 millions as compared to 500.50 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 5872.10 5724.90 2.57 22171.10 21840.20 1.52 22171.10 21840.20 1.52
Other Income 87.20 69.30 25.83 255.70 320.40 -20.19 255.70 320.40 -20.19
PBIDT 1045.10 500.50 108.81 2520.90 2883.20 -12.57 2520.90 2883.20 -12.57
Interest 48.80 23.40 108.55 164.70 82.90 98.67 164.70 82.90 98.67
PBDT 996.30 477.10 108.82 2356.20 2661.00 -11.45 2356.20 2661.00 -11.45
Depreciation 121.00 110.10 9.90 461.30 432.60 6.63 461.30 432.60 6.63
PBT 875.30 367.00 138.50 1894.90 2228.40 -14.97 1894.90 2228.40 -14.97
TAX 222.60 89.50 148.72 495.10 571.80 -13.41 495.10 571.80 -13.41
Deferred Tax 36.80 2.10 1652.38 32.50 1.70 1811.76 32.50 1.70 1811.76
PAT 652.70 277.50 135.21 1399.80 1656.60 -15.50 1399.80 1656.60 -15.50
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 17.80 8.74 103.58 11.37 13.20 -13.87 11.37 13.20 -13.87
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..